Andrew Kronk

Andrew Kronk is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as the Skill Enablement Lead at Genentech since January 2017. In this role, Andrew establishes a comprehensive understanding of the CMG enterprise, leveraging data and stakeholder insights to craft innovative solutions while demonstrating leadership qualities such as expertise and accountability. Prior to this, Andrew held multiple positions at AstraZeneca, including Compliance & Ethics Leader, where responsibilities included monitoring sales activities and providing compliance training, and District Sales Manager, focusing on sales leadership across various therapeutic areas. Andrew's career began at EPI as an Account Executive and includes significant training and sales roles at AstraZeneca, showcasing a strong collaboration with cross-functional teams and adaptation to market changes. Andrew holds a Bachelor of Science degree in Biology from Central Michigan University.